The National Cancer Institute’s (NCI) Alliance for Nanotechnology in Cancer and the Center for Advancing Innovation have partnered to create a “first of a kind” Nanotechnology Startup Challenge in Cancer or NSC2.Continue reading
Category Archives: Health
Scientists determine structure of important drug target using groundbreaking approach
Tempe, Arizona (July 23, 2015) – Using the brightest X-ray laser in the world, scientists have determined the structure of a molecular complex that is responsible for our sense of sight.Continue reading
Paradigm Initiates Genomic Profiling for Pharmatech’s AccessPPM Cancer Registry Program
Novel clinical trial matching protocol enables greater access to genomic profiling and targeted clinical studies for cancer patients nationwide.Continue reading
NAU Reseachers Study Link Between Uranium Exposure And Skin Cancer,
After years of delving deep into DNA and researching ways in which metal damage may lead to cancer, a team of researchers is taking a step back to look at the surface where one answer may have been all along.Continue reading
Biodesign’s Arntzen using tobacco as a way to make and deliver a promising vaccine for the Ebola virus
Charlie Arntzen has worked tirelessly on new platforms to deliver vaccines. He has focused on plant-based vaccine delivery systems, testing a wide range of plants as possible “manufacturing platforms” for vaccines for the developing world.Continue reading
UA Researchers Exploring If Diet Can Make You Live Longer
UA Researchers Study Increasing Lifespan and Immune FunctionContinue reading
FDA Approves the SynCardia Total Artificial Heart With SynHall Valves
SynCardia Systems, Inc., now controls last key component in heart manufacturing.Continue reading
NuvOx announces Phase Ib trial for Glioblastoma and additional NIH funding
NuvOx Pharma, a privately held biotechnology company based in Tucson, Arizona, announced that on July 14th, it began a Phase Ib clinical trial of its new drug NVX-108 in patients with glioblastoma, a deadly form of brain cancer.Continue reading
The Freedom® portable driver from SynCardia Receives FDA Approval for Bridge to Transplant
TUCSON, Ariz. – July 16, 2014 – The Freedom® portable driver received FDA approval on June 26, 2014 for use with the SynCardia temporary Total Artificial Heart as a bridge to transplantation in cardiac transplant candidates who are clinically stable.Continue reading
UA Discovery Shows Curcumin Effect on Colon Cancer
TUCSON, Ariz. – A team of researchers led by the University of Arizona Steele Children’s Research Center discovered that curcumin—the bioactive molecule derived from the spice turmeric—blocks the protein cortactin in colon cancer.Continue reading